Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: St. Jude

This article was originally published in The Gray Sheet

Executive Summary

St. Jude: Initial implants of the firm's Angstrom MD and Contour MD implantable cardioverter defibrillator devices are performed in two patients Oct. 17 at the University of Kentucky Hospital, Lexington, following St. Jude's Oct. 2 receipt of an investigational device exemption to study the morphology detection technology incorporated in the single-lead ICD systems. The morphology detection algorithm enables the device to discriminate between atrial arrhythmias and ventricular arrhythmias "based on the characteristics of their electrogram complexes," St. Jude claims. The U.S. study will consist of 20 sites and will enroll 65 patients. European trials of the devices are ongoing ("The Gray Sheet" June 23, I&W-6)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT038321

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel